|
The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field
RECRUITINGN/ASponsored by University of Aberdeen
Actively Recruiting
PhaseN/A
SponsorUniversity of Aberdeen
Started2020-08-01
Est. completion2025-07-31
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04458883
Summary
The main aim of the study is to build and test a cardiac-specific coil purposely assembled in house to suit the FFC-MRI whole-body prototype and to test if it could be used for clinical cardiac scans in human subject populations.
Eligibility
Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria: * Participant who is willing and able to give informed consent for participation in the study * Healthy volunteers willing to give informed consent for participation in the study * Patients diagnosed with a previous myocardial infarction Exclusion Criteria: * Unwillingness to participate * Claustrophobia * Contraindication to MRI scanning such as implantable cardiac devices * Participants who have had a previous myocardial infarction in the past of which they may not be aware and this is discovered whilst being scanned on the 3T MRI scanner, or who may have any other cardiology condition that they were previously unaware will not be included in the healthy control group, even if they present themselves to us as "healthy" at the time of the study visit * Pregnancy * Body habitus that may preclude comfortable positioning of the volunteer in either of the MRI scanners (\>50cm in diameter) * Participants with abnormal kidney function that will preclude them from receiving a contrast agent
Conditions2
Heart DiseaseMyocardial Infarction
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Aberdeen
Started2020-08-01
Est. completion2025-07-31
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04458883